AMALY — SHARIAH COMPLIANCE REPORT ================================== Symbol: ARTL Report Date: 2026-04-10 Full Report: https://amaly.io/stock/ARTL EXECUTIVE SUMMARY ------------------ Compliance Status: NON_COMPLIANT Quality Rating: B Description: ARTL, operating in an unknown industry, demonstrates strong financial ratios with low debt (2.87%) and adequate liquidity (22.56%), but insufficient data on income sources and primary business activities in cannabinoid therapeutics raise significant Shariah compliance concerns. The company fails business activity screening due to involvement in potentially haram substances, leading to non-compliance across major indices. While financial metrics support compliance, qualitative business review dominates the assessment. Purification is not required based on available data, but investors should monitor for updates. Overall, ARTL is not recommended for Shariah-compliant portfolios without further scholarly review. Primary Compliance Concerns: - Business activity in cannabinoid therapeutics classified as non-compliant due to association with intoxicants - Insufficient data on interest and non-permissible income ratios - Exclusion from all major Shariah indices due to business screening failure Purification Requirement: 0.00% Index Inclusion: Not included in S&P Dow Jones Shariah Indices, MSCI Islamic Indices, FTSE Shariah Indices, or Dow Jones Islamic Market (DJIM) KEY FINANCIAL METRICS ---------------------- Debt Ratio: 0.0% Liquidity Ratio: 0.0% Interest Income Ratio: 0.0% Purification Required: 0.00% INDEX INCLUSION STATUS ----------------------- S&P Shariah: EXCLUDED MSCI Islamic: EXCLUDED DJIM: EXCLUDED FTSE Shariah: EXCLUDED Total: 0 of 4 Last Verified: 2025-12-31 REPORTING PERIOD ----------------- Latest Annual Report: FY 2025 Latest Quarterly Data: Q4 2025 Trend Period: FY 2020 to FY 2025 Data Retrieved: 2026-02-22T12:00:00Z --- Full interactive report: https://amaly.io/stock/ARTL Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.